process that involves many modifications including protoMutation spectra of the p53 gene from human skin carcinoncogenes and tumor suppressor genes. Among these, the p53 omas have been connected to solar UV radiation. For tumor suppressor gene has all the characteristics required for comparison we have characterized the mutation spectrum analyzing mutation spectra in tumors and enables elucidation of the p53 gene in a very large sample of squamous of the events involved in the initiation of cancers (5) . It is by cell carcinomas from hairless mice induced with UV of far one of the most frequently mutated genes found in human wavelength 280-320 nm (UV-B), which have substantiated cancers and can be functionally altered at more than a hundred the mutagenic effects of UV-B radiation in vivo. Tumors different codons, which code for the amino acids clustered in from hairless mice, random bred SKH:HR1 as well as the central hydrophobic region of the protein. Although all inbred SKH:HRA strains, which are analyzed for mutations possible types of mutations have been documented, the majority in the conserved domains of the p53 protein present a consists of missense mutations. Moreover, the large database very specific mutation spectrum. The observed mutation containing Ͼ4500 mutations of the p53 gene in human cancers frequency after chronic UV-B radiation in the p53 gene (6) has allowed the comparison of mutation spectra among ranged from 54% (SKH-HRA) to 73% (SKH-HR1) among different classes of human tumors. the 160 tumors analyzed. Over 95% of the mutations were It has already been shown that the p53 mutation spectrum found at dipyrimidine sites located in the non-transcribed in human skin cancers is significantly different from those strand, the majority were C→T transitions and 5% were observed in other human cancers but very similar to those CC→TT tandem double mutations. Four distinct UV-B observed in UV-treated target genes in model systems (2,3). mutation hot spots have been identified for the first time:
In human skin carcinomas, p53 mutations are mainly C→T two major ones at codons 267 (33%) and 272 (19%) and transitions located on dipyrimidine sites that are specific UV two minor ones at codons 146 (10%) and 173 (4%). The targets, whereas in internal cancers C→T are mainly located at codon 267 hot spot consists of a CpG preceded by a CpG sites. Moreover CC→TT tandem substitutions, generally pyrimidine, which confirms in vivo an important role for recognized as being the characteristic fingerprint of UV lesions, this UV-B mutable site in UV-B-induced skin tumors that are frequently found in human skin carcinomas (7) (8) (9) (10) (11) . is not found in other types of mouse tumors. Comparison Skin carcinogenesis experiments with animal models, parwith mutation spectra from human skin carcinomas fully ticularly the mouse, have already yielded a lot of data on how validates the merits of the hairless mouse model for studying skin tumor development depends on dose, time and wavelength the molecular mechanisms of skin carcinogenesis. For of the UV-radiation (12) . Indeed, murine skin cancers induced example, the murine hot spot at codon 272 does have a by repeated exposure to UV radiation provide an excellent full equivalent in human skin carcinomas. In contrast, the model system for investigating the molecular mechanisms of human equivalent of the murine codon 267 lacks the dipyrimidine site and therefore fails to be a pronounced UV carcinogenesis, since UV radiation is the only carcinogenic hot spot in human skin carcinomas; however, this site is agent known once other known risk factors are carefully one of the major hot spots in human internal cancers controlled for or eliminated. In particular, studies on hairless (evidently not induced by UV radiation but probably by mice have demonstrated that wavelengths in the UV-B (280-deamination of the 5 methyl cytosine).
320 nm) region of the solar spectrum are the most carcinogenic (13) . Therefore, in the present study we were particularly interesIntroduction ted in looking for p53 alterations in UV-B-induced murine skin cancers in order to investigate whether the relationship The carcinogenicity of sunlight to the skin has been recognized between oncogenetic changes and the UV radiation described for nearly a century and various experimental studies have for human non-melanoma skin cancers could be confirmed in the hairless murine model. Up to now, the data from various (for gels without glycerol). After migration, gels were dried and subjected to autoradiography. The entire procedure was repeated at least twice for each the involvement of UV-induced damage in p53 modifications sample. When shifted bands were observed, they were cut out of the gel, the in squamous cell carcinomas (SCC*). Moreover, the p53 DNA was eluted in distilled water and reamplified as described.
protein is a highly conserved molecule that allows data from
Purification and sequencing of the PCR products animal models to be extrapolated to man. Hence, for the first
The PCR products were purified on an agarose gel and the DNA extracted time, the present study has allowed us to compare the very using the Nucleotrap kit (Macherey Nagel, Germany). Purified products were specific p53 mutation spectra obtained from our large study and substantiated in more detail the role of UV-B in solar mutagenesis and skin carcinogenesis in man.
Group II

Immunohistochemistry
Materials and methods
Immunohistochemical staining was carried out on deparaffinized 5-µm sections, using the CM-5 polyclonal antibody (kindly provided by Dr David Tumor induction and DNA isolation: Groups I and II Lane) and counterstained with hematoxylin as previously described (16) . For The experimental procedure used for tumor induction by chronic UV-B histological diagnostic purposes, serial sections of all samples were also radiation in albino hairless mice has been previously described in detail (17) .
stained with hematoxylin and eosin (H&E). In brief, SKH-HRA (inbred strain, 18 mice) or SKH-HR1 (random bred, 40
DNA amplification mice) mice were irradiated daily for 75 min intervals with UV-B, starting at Exons 4 to 8 of the p53 gene were individually amplified from DNA isolated 10 weeks of age. The daily surface exposure on the dorsal area of the mice from tumors and control tissue as described previously (16) . The following was 150 mJ/cm 2 of UV emitted from Westinghouse FS40 sun-lamps (with a pairs of primers, in which 'e' and 'i' stand for exon and intron respectively, maximum output wavelength around 310 nm). After 10 weeks the first tumors were used. Sense (s) represents the 5Ј oligo whereas antisense (as) represents appeared and after 25 weeks all mice had multiple dorsal skin tumors. Group the 3Ј oligo I mice were killed at 25 weeks and six Group II mice were killed at week 18 Exon 4: e4m2s: 5Ј-CCCCTGTCATCTTTTGTCCC-3Ј and 12 Group II mice at week 25. After killing, the tumors were carefully i4las: 5Ј-TCAGGGCAAAACTAAACTCT-3Ј removed. Tumors collected from the SKH-HR1 mice were designated Group Exon 5: i4rs: 5Ј-AGTTCCCCACCTTGACACCT-3Ј I and analyzed in Villejuif, whereas tumors from the SKH-HRA strain were i5ras: 5Ј-AGAGCAAGAATAAGTCAGAA-3Ј designated Group II and analyzed in Bilthoven. To prepare tumor tissue for Exon 6: i5rs: 5Ј-ACTGGCAGCCTCCCATCTTCCC-3Ј histology and immunohistochemical analysis of p53, only a portion of the i6las: 5Ј-GTCAACTGTCTCTAAGACGCA-3Ј tumors from Group II was formalin fixed for Ϯ 18 h and paraffin embedded Exon 7: i6rs: 5Ј-TGTAGTGAGGTAGGGAGCGAC-3Ј according to routine procedures. The other portion, or for Group I the whole i7las: 5Ј-CTGGGGAAGAAACAGGCTAA-3Ј tumor, was snap-frozen in liquid N 2 and stored at -80°C for molecular Exon 8: i7rs: 5Ј-CTTGTGCTGGTCCTTTTCTTG-3Ј analysis. Isolation of DNA for mutation analysis was performed as described i8las2: 5Ј-AGGAGAGAGCAAGAGGTGACT-3Ј previously for Group I (18) and by other standard methods (19) for Group II.
The PCR conditions were as follows. Genomic DNA (100-200 ng) was incubated in a total volume of 100 µl with 0.5 µM of each primer, 250 µM
Group I
of dNTPs, PCR buffer (50 mM KCl, 10 mM Tris-HCl pH 8.3, 3 mM MgCl 2 .6H 2 O, 0.001% gelatine) and 2.5 U of Taq polymerase (Perkin-Elmer).
Single-strand conformation polymorphism (SSCP) analysis
After an initial denaturation of 5 min at 95°C, amplification was performed The coding region of the p53 gene corresponding to the central region of the for 30 cycles consisting of 30 s at 95°C, 1 min at 55°C and 2 min at 72°C protein was amplified by using six sets of primers covering exons 5, 6, 7 and using a Perkin-Elmer Thermal Cycler 9600. The concentration and length of 8. To avoid amplification of the mouse p53 pseudogene, all primers were the amplified fragments was checked by electrophoresis on a 3% agarose gel located in the introns or spanned the intron-exon junctions. The following (FMC Bioproducts, USA). Direct sequencing of the PCR products was primer couples were used: ME5F-ME5R for exon 5, ME5F-ME5-6R for performed as described previously (16) . exons 5 and 6, ME7F-ME7R1 and ME7F-ME7R2 for exons 7, ME8F1-ME8R1 and ME8F2-ME8R2 for exon 8. The sizes of the amplified fragments this study was essentially for practical reasons as only the collected at week~25. A non-selective subset of these lesions Group II (SKH-HRA). Direct sequencing of exons 4 to 8 of were characterized histologically (H&E staining). The early the p53 gene was carried out on 43 SCC isolated from 18 lesions corresponded to actinic keratosis (AK) in man, which mice as well as on five normal skin biopsies. In 57% (8/14) are considered to represent pre-malignant precursors of SCC.
of the tumors isolated after 18 weeks and in 52% (15/29) of These early pre-cancerous lesions were frequently of the the tumors isolated after 25 weeks, at least one base substitution hypertrophic (papillomatous) form. Due to the histopathologin the p53 gene was observed. Because the difference between ical heterogeneity within such a lesion and the often limited these two subgroups is not statistically significant, we pooled size of tumor sample, not all aspects of actinic keratosis (such the two and calculated that the average frequency to be 53%. as dysplasia) could be equally well demonstrated. Nevertheless Among the mutated samples, five carried two independent these lesions were tentatively diagnosed as actinic keratosis.
mutations, which is in agreement with the findings in Group In a number of cases the skin lesions showed severe dysplasia I. All mutations for this group are listed in Table I . The and frank (local) invasion, leading to the diagnosis of SCC.
presence of wild-type p53 sequences noted for Group I also All p53 mutation analysis carried out in Group II was on SCC.
pertains to Group II.
Frequency of p53 mutations
Immunohistochemistry Once the tumors from the two groups were analyzed, the two Group II (SKH-HRA). A total of 83% (29/35) of the samples different methods applied by both laboratories were compared showed positive immunostaining with the CM-5 polyclonal to each other by exchanging some 20 isolated tumor DNAs.
antibody, which comprised 10-80% of the cells in the lesion. The outcome of this comparison confirmed the prevalence and
The type of nuclear immunostaining was basically the same types of mutations detected (Table I) . However, at present, it as described previously (16) . A typical example of tumors is not clear yet whether the observed statistically significant collected at week 18 and week 25 from Group II is presented difference between the frequencies for the SKH-HRA (53%)
in Figure 1 . The positive predictive value of IHC for mutations and the SKH-HR1 (73%) mice was really strain-specific or in the conserved domains was 46%, whereas in 34% of the caused by a higher sensitivity of the SSCP method in detecting samples overexpression of p53 was observed in the absence low abundance mutated alleles in a heterogeneous sample. It of any detectable mutations in the domains investigated. In is, however, important to note that SSCP analysis for codon~1 0% of the cases, mutations were found without accompany-267 in exon 8 needed an adaptation (see Materials and methods ing positive IHC. Finally, p53 immunostaining was clearly section) to prevent an underestimation of mutations at this visible in precursor lesions of AK already collected after 10 position. This may be the reason why this important hot spot weeks of UV-B irradiation, although the staining was mainly has not been recognized in earlier studies of UV-B induced confined to the basal layer (data not shown). p53 mutation in the mouse (14, 15) .
Characteristics of the p53 mutation spectrum Groups I and II. All the mutations observed were missense Group I (SKH-HR1). The combined used of PCR and SSCP mutations, except for one nonsense mutation and two silent has provided a simple and sensitive method for the detection mutations located on the third base of the codon, which were of point mutations. It has been observed that, depending on running conditions and primers used for PCR amplification, both associated with a second mutation in the sample. As efficiency of the SSCP analysis may vary with the sequence shown in Tables I and II , most mutations (Ͼ80%) are C to T context targeted for the screening of mutations (20, 21) . Recent transitions, which are mainly located at CC and TC sites, with results on different loci have proved that the combined use only a few (4/114) located at non-dimer CpG sites. However, of different running conditions can enhance the detection when a CpG site like the one at codon 267, was preceded by sensitivity of this technique by up to 80-100% (22, 23) . a pyrimidine, thereby providing a putative cyclobutane dimer Therefore to avoid underestimating the number of mutations site, a high mutation frequency was observed. Tandem substituin the p53 gene detected by the SSCP analysis, several sets of tions were frequent (10%) and consisted mainly of the characprimers and different gel running conditions were used in our teristic CC→TT tandem transition. All but two tandem study for each exon analyzed. SSCP analysis of exons 5 to 8 substitutions resulted in a single amino acid change. Nearly of the p53 gene was carried out on 117 SCC as well as on all mutations were targeted at dipyrimidine sites known to be four control normal skin biopsies. A total of 73% (85/117) of UV photolesion hot spots [cyclobutane pyrimidine dimers or the tumors analyzed presented at least one base substitution pyrimidine(6-4)pyrimidone photoproducts]. Association of the on the p53 gene whereas normal skin biopsies contained only mutations with a dipyrimidine target site on the transcribed or wild-type sequences. All the mutations are listed in Table I. the non-transcribed strand of the p53 gene, demonstrated a Among all mutated samples, 22 carried two distinct mutations strong strand bias towards the non-transcribed strand of the and three tumors carried three distinct mutations. The fact that p53 gene. Figure 2 shows the distribution of mutations along 20% of the tumors contained multiple mutant alleles suggests the p53 gene. They were mainly (96%) located at evolutionary that either the tumors were made up of heterogeneous populaconserved regions of the gene and many have contributed to tion of cells or that mutant alleles with single base changes were the four hot spots of mutations observed (amino acids 146, targets of secondary mutation events, because of continued 173, 267 and 272). exposure to UV radiation during tumor progression. Further-
Comparison of the murine and the human p53 mutation spectra more wild-type sequences were always present together with
In order to ascertain the functional relevance of the p53 mutated sequences in tumors, and the ratio of mutated to mutation spectrum that was found in UV-B-induced murine wild-type sequence varied considerably between the samples skin cancer, we compared it to the p53 mutation spectra analyzed. The detection of signals for the wild-type allele was found in normal human skin cancers or in skin cancers from due either to the presence of normal tissue in the tumor biopsies or because only one allele had mutated. xeroderma pigmentosum (XP) patients. XP is a rare inherited 
Discussion
The specificity of p53 mutations in UV-B-induced murine skin cancers
The analysis of mutation spectra has proven to be a powerful tool in identifying (solar) UV light as the major carcinogen for skin cancers by virtue of the unique and characteristic pattern of mutations created by it. It is obvious from the data presented here that the p53 mutation spectrum observed in (25, 26) . These characteristics include the the highly conserved domains of the p53 protein are represented above the location of nearly all mutations (96%) on dipyrimidine graph according to Soussi et al. (24) . There is a codon numbering sequences known to be targets for UV-induced photolesions, discrepancy between the human and mouse coding sequences, so codon 272 (mouse) corresponds to codon 278 (human) etc. such as cyclobutane pyrimidine dimers and pyrimidine(6-4)pyrimidone photoproducts, while py-py sites are distributed randomly over the p53 gene. Moreover, most mutations (81%) disease characterized by a deficiency in DNA repair associated with an extremely high level of skin tumors on exposed sites are GC to AT transitions whose presence could be explained by the hypothetical 'A rule' whereby the DNA polymerase is of the body. In a previous study we characterized the p53 mutation spectrum in a series of cutaneous carcinomas from thought to incorporate preferentially an adenine opposite a non-instructive dipyrimidine photolesion. More significantly, patients with XP (10). The mutations were almost all located at dipyrimidine sites. They were characterized by a high level a high level (10%) of tandem mutations, especially CC→TT double transitions, are found in the p53 gene in murine skin of C→T and especially CC→TT transitions with the py-py sequences exclusively located on the non-transcribed DNA cancers. These tandem substitutions are very characteristic of UV-induced mutagenesis and are considered an essential part strand of these excision-repair deficient patients (10) . Table II shows that the substitution type and their location at dipyrimidof the fingerprint in UV photolesions, although it should be realized that oxidative damage can also result in CC→TT ine sites are similar in murine and normal human skin cancers [data taken from several studies, see Reference (2) for review] double transitions, although at a very low frequency (27) . Interestingly, in eight of the 15 sites where tandem mutations and even more so in murine and XP skin tumors. The frequency of tandem substitutions was nearly the same in murine and were detected, the first mutation occurred on the third base of the 5Ј codon and hence there was no change in the first amino non-XP human skin cancers whereas this frequency was significantly higher in XP tumors. The only significant differacid involved in the mutation site. This clearly indicates that there was no selection pressure for this mutation and therefore ence between murine and human skin cancers was the strand (11) 9 (5) 12 (14) 2 (4) GC→CG 2 (2) 0 (0) 2 (1) (11) 4 (10) 16 (10) 10 (14) 16 (55) (% of tandem mutations) Substitution location (tandem taken as one event) Py-Py site 111 (97) 36 (93) 150 (96) 65 (88) 45 (100) Non-Py-Py site 3 (3) 3 (7) 6 (4) 9 (12) 0 (0)
Py-Py site location Non-XP XP-C ϩ XP-A Transcribed strand 8 (7) 2 (6) 10 (7) 30 ( the high level of tandem mutations observed was not due to stopped 72 h before the tumors were collected to avoid any some specificity of the p53 biology but only to the typical discrepancy that might arise from any physiological response. signature of UV-induced lesions. If the four sites where both As in the three previous reports on UV-B-induced murine tandem and identical unique mutations on the same codon are skin tumors (14-16) we have observed that most of the pooled, resulting in the same amino acid changes (codons mutations of the p53 gene (91%) are due to photolesions 123-124, 257-258, 263-264 and 271-272), then the frequency located on the non-transcribed strand of this gene. This strong of tandem mutations is 28% on average, while the frequency strand bias is a reflection of the DNA repair mechanisms in of unique mutations is 72%. At CC sites, the probability of rodent cells. Recent results have shown that cyclobutane inducing tandem mutations is therefore quite high.
pyrimidine dimers, which are one of the most prominent UVThe data we have obtained from this large study clearly induced DNA lesions, are preferentially removed from the substantiates a major role for UV-B-induced photoproducts transcribed strand and are hardly, or only very slowly, eliminat dipyrimidine sites in murine p53 mutagenesis and skin ated from the non-transcribed strand of the HPRT and the p53 carcinogenesis. Furthermore, these results directly incriminate genes in rodent cells, as had been already observed in the XP the loss of the p53 tumor suppressor function in the pathogengroup C cells (30,31). esis of UV-induced skin carcinomas in mice, and this can be
Comparison of the murine and human p53 mutation spectra used as an analogy to skin carcinomas in man (2,3). Recent
The vast amount of data from human and mouse models have results in humans and mice even indicate that the alteration proven the suitability of the p53 gene as a probe for studying of the p53 gene by UV is probably an early event in the skin mutagenesis. Good examples of a direct association between carcinogenesis process (11, 28, 29) .
a specific carcinogen and a particular cancer has been seen by The positive predictive value of IHC for mutations in the studying the human p53 gene alteration patterns in lung cancers conserved domains of the p53 gene is 46% in this study, associated with benzo[a]pyrene found in cigarette smoke (32) , confirming the view put forward by Greenblatt et al. (5) that in liver cancers associated with aflatoxin B1 consumption (33) the status of the p53 protein by IHC cannot be equated with and in skin cancers associated with solar exposure (2,3). the wild-type or mutant genotype. This point has been fully An important feature of the p53 protein is that it is discussed by Greenblatt et al. (5) , including the hypothesis highly conserved among vertebrates and therefore allows the that mutations that occur in genes downstream of p53 which can extrapolation of carcinogenesis studies in animals to humans. control p53 activity by feedback mechanisms. It is important to For this reason, to assess the relevance of the hairless mouse note, that we could discriminate quite clearly, based on the model to human skin carcinogenesis, and hence evaluate the intensity of the CM-5 antibody staining, between a physiologirole of UV-B radiation in human skin carcinoma induction, cal response to DNA damage and a tumor related staining, we have compared the results obtained in two separate UVbecause p53 staining seen as a response to DNA damage is less intense (29) . Moreover, UV irradiation of the mice was B-induced murine skin cancer studies with those observed in sun induced human skin cancers (Table II and Figure 2) . been defined in the murine p53 gene as yet, but their importance is clear: one of the two major UV-B murine hot spots that Although p53 mutation spectra in mice and human skin cancers were both UV-specific, they are not completely identical. GC have been found at codon 272 corresponds to the human codon 278 skin cancer hot spot, which is known to be slowly repaired to AT transitions are less frequent in skin tumors from normal individuals than in murine skin tumors, and substitutions are (38). This codon is not a mutation hot spot in internal tumors and thus confirms the importance of UV induced photolesions slightly more frequently found at dipyrimidine sites in murine and XP skin cancers than in normal human skin tumors. It is at this site in both the murine and human p53 gene. Significantly, the other murine codon 267 mutation hot spot is an not clear whether these differences reflect differences in the DNA repair process between rodent and normal human cells important UV-B mutable site, as it is a CpG preceded by a pyrimidine, whereas the equivalent human codon 273 is not a or reflect the role of factors other than UV-B, for example UV-A in human skin carcinogenesis. As previously described, pronounced hot spot in human skin cancers as it lacks this dipyrimidine site. It should be noted that these mutations at it has been demonstrated in mice that, dipyrimidine photolesions are preferentially removed from the transcribed strand codon 267 have only been found in studies of UV-B induced murine skin cancers (14) (15) (16) and not in other types of mouse and barely from the non-transcribed strand of active genes (30,31). This preferential repair of pyrimidine dimers also tumors induced by a variety of carcinogens. In fact, in a mutation data base consisting of over 200 murine p53 exists in human cells (34, 35) but repair on the non-transcribed strand is faster than in murine cells. This variation in the repair mutations, we have established that only one mutation is found at codon 267 and that the base that is changed is not the one process explains the differences observed in the strand bias for p53 mutations between murine and non-XP human skin involved in the majority of our UV-B induced codon 267 mutations. Hence, we can assume that UV-B is directly cancers, and could explain the divergence between these two p53 mutation spectra. In fact, cells from the highly deficient responsible for the mutations found at codon 267 in these tumors and that this mutation is strongly selected in the UVrepair group, XP-C, like rodent cells, repair only the transcribed strand of active genes, and indeed we found that all mutations B-induced murine skin carcinogenesis process. This amino acid is the equivalent of the human 273 amino acid, which is of the p53 gene in skin tumors from these patients were due to unrepaired UV-photolesions on the non-transcribed strand essential for the specific DNA binding activity of the human p53 protein, like the human amino acid 248, which is a (10). This similarity in the DNA repair process between XP-C and mouse cells is therefore reflected by the same strand mutation hot spot in human skin cancers. The variation in DNA-repair processes and slight interspecies variations in the bias for p53 mutations, but also very strikingly, by an almost identical mutation pattern when the type of base substitution DNA sequence of p53 could then explain the disparity in mutation distribution between human and murine tumors. and its location is considered (Table II) .
Another hypothesis for explaining the differences between The overall data presented here on UV-B-induced murine skin tumors confirms the role of UV-induced damage in murine and human p53 mutation spectra takes into consideration the role of factors other than UV-B, for example UV-A in the p53 tumor suppressor gene inactivation during the skin carcinogenesis process. They also support the usefulness of the pathogenesis of skin cancers. UV-A radiation (Ͼ320 mm), which constitutes Ͼ90% of the solar energy, probably acts the hairless mouse as it is only possible in animal models to evaluate the specificity of the UV wavelengths implicated in indirectly on DNA through interactions with cellular chromophores that subsequently generate reactive oxygen species skin tumor induction and progression. Moreover, transgenic mice carrying mutated repair genes provide unique tools for (ROS) (27) . These ROS usually attack G or A bases, and one of the base alterations produced by singlet oxygen is analyzing the role of repair systems in counteracting the deleterious effects of UV irradiation. Finally, comparison of hydroxyguanine, which by mispairing with an A induces G→T transversions (36) . This type of substitution represents 14% of mouse p53 mutation spectra with those obtained from humans strengthens the role of (solar) UV-B in human skin carcinoma the p53 mutations in solar-induced human skin cancers but is rarely observed in UV-B-induced murine tumors (χ 2 test; P Ͻ induction by solar irradiation, and also indicates the possible involvement of other factors such as UV-A. 0.02). This significant difference could reflect the role of UV-A in human skin carcinogenesis. Only a few UV-A-induced mutation spectra have been reported in rodent or human cells
